RTN4R and neurodegenerative disease: Since inhibition of the Nogo-A/NgR signaling pathway in microglia has been shown to enhance the clearance of harmful substrates in the CNS, antagonizing the Nogo-A/NgR pathway and improving the phagocytic capacity of activated microglia can be used as a therapeutic strategy to ameliorate neurodegenerative diseases.